SCHEMBL835926

SCHEMBL835926

COC(=O)C1CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL526666 1.00
SCHEMBL3719824 1.00
SCHEMBL15129727 0.89 CYP2D6 (0.43)
Ammonia Solution, Strong SCHEMBL28228477 0.87 CYP2D6 (0.42)
SCHEMBL29573620 0.87 CHRNB2 (0.38)
SCHEMBL25022698 0.87 CHRNB2 (0.38)
Trifluoroacetic Acid SCHEMBL17984344 0.85 CHRNB2 (0.37)
Trifluoroacetic Acid SCHEMBL17981421 0.85 CHRNB2 (0.37)
SCHEMBL5787505 0.84
SCHEMBL13403380 0.82 CHRNB2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230114829-A1 COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS LANDA LABS (2012) LTD. (IL) 2023-04-13 US claimed
EP-4146161-A1 COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS Landa Labs (2012) Ltd. (IL) 2023-03-15 EP claimed
WO-2021224785-A1 COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS LANDA LABS (2012) LTD. (IL) 2021-11-11 WO claimed
CN-104628619-A Preparation method of cell growth inhibitor anticancer drug namely ranitidine and related derivatives DONGLI NANTONG CHEMICALS CO LTD 2015-05-20 CN claimed
US-20050059068-A1 Compositions and methods using dendrimer-treated microassays STRATAGENE CALIFORNIA 2005-03-17 US claimed
US-20260070896-A1 HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2026-03-12 US disclosed
US-12404266-B2 Heterocycle derivatives for treating TRPM3 mediated disorders KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2025-09-02 US disclosed
CN-115873020-B RAS inhibitors 锐新医药公司 2025-06-13 CN disclosed
EP-4559902-A2 KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE Imago Biosciences Inc. (US) 2025-05-28 EP disclosed
WO-2025082467-A1 IMMUNOMODULATORS 成都先导药物开发股份有限公司 2025-04-24 WO disclosed
US-20250057957-A1 SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION C4 THERAPEUTICS, INC. (US) 2025-02-20 US disclosed
US-12209081-B2 Heterocycle derivatives for treating TRPM3 mediated disorders KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2025-01-28 US disclosed
US-20020115068-A1 Screening library to detect interacting protein; obtain library of proteins, incubate with microarray, monitor sample for protein activity DOMANTIS LIMITED (GB) 2002-08-22 US disclosed
CN-1345308-A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors AMERICAN CYANAMID CO (US) 2002-04-17 CN disclosed
CN-1232457-A 1,4-heterocyclic metalloprotease inhibitors PROCTER & GAMBLE (US) 1999-10-20 CN disclosed
US-5371135-A Hot melt adhesives, water soluble, alkali soluble, pigment dispersibility; modifiers with hydroxy, amino, mercapto and aziridnyl functional groups and a transition metal compound; grafted with acrylic or vinyl polymers and tackifier resin TOYO INK MANUFACTURING CO., LTD. (JP) 1994-12-06 US disclosed
US-5298568-A Water soluble or dispersable TOYO INK MANUFACTURING CO., LTD. (JP) 1994-03-29 US disclosed
US-4677199-A Reactive dyes containing substituted 4-fluoropyridaz-6-one radicals BASF AKTIENGESELLSCHAFT (DE) 1987-06-30 US disclosed
EP-0079390-B1 PROCESS FOR PREPARING BETA-HYDROXY AMINO ACID MITSUI TOATSU CHEMICALS, Inc. (JP) 1985-12-27 EP disclosed
EP-0079390-A1 PROCESS FOR PREPARING BETA-HYDROXY AMINO ACID MITSUI TOATSU CHEMICALS, Inc. (JP) 1983-05-25 EP disclosed